This is so undervalued. Look at any other biotech of the sort. Many are +$1 and don't have half the network, organization, and transparency that RCHA has. This is going places. I'm holding and adding on the lows. GL all
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.